These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 36611367)

  • 1. Mucopolysaccharidosis: What Pediatric Rheumatologists and Orthopedics Need to Know.
    Costi S; Caporali RF; Marino A
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn screening and diagnosis of mucopolysaccharidoses.
    Tomatsu S; Fujii T; Fukushi M; Oguma T; Shimada T; Maeda M; Kida K; Shibata Y; Futatsumori H; Montaño AM; Mason RW; Yamaguchi S; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):42-53. PubMed ID: 23860310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy.
    Maccari F; Rigon L; Mantovani V; Galeotti F; Salvalaio M; D'Avanzo F; Zanetti A; Capitani F; Gabrielli O; Tomanin R; Volpi N
    J Mol Med (Berl); 2022 Aug; 100(8):1169-1179. PubMed ID: 35816218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis.
    Cimaz R; Coppa GV; Koné-Paut I; Link B; Pastores GM; Elorduy MR; Spencer C; Thorne C; Wulffraat N; Manger B
    Pediatr Rheumatol Online J; 2009 Oct; 7():18. PubMed ID: 19852785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
    de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
    Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure.
    de Ru MH; Boelens JJ; Das AM; Jones SA; van der Lee JH; Mahlaoui N; Mengel E; Offringa M; O'Meara A; Parini R; Rovelli A; Sykora KW; Valayannopoulos V; Vellodi A; Wynn RF; Wijburg FA
    Orphanet J Rare Dis; 2011 Aug; 6():55. PubMed ID: 21831279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucopolysaccharidosis type I.
    Wraith JE; Jones S
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn Screening Program for Mucopolysaccharidosis Type II and Long-Term Follow-Up of the Screen-Positive Subjects in Taiwan.
    Lin HY; Chang YH; Lee CL; Tu YR; Lo YT; Hung PW; Niu DM; Liu MY; Liu HY; Chen HJ; Kao SM; Wang LY; Ho HJ; Chuang CK; Lin SP
    J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient.
    Fox JE; Volpe L; Bullaro J; Kakkis ED; Sly WS
    Mol Genet Metab; 2015 Feb; 114(2):203-8. PubMed ID: 25468648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: Divergent clinical outcomes in two Japanese siblings.
    Yamazaki N; Kosuga M; Kida K; Takei G; Fukuhara Y; Matsumoto H; Senda M; Honda A; Ishiguro A; Koike T; Yabe H; Okuyama T
    Brain Dev; 2019 Jun; 41(6):546-550. PubMed ID: 30755342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucopolysaccharidoses I and II: Brief Review of Therapeutic Options and Supportive/Palliative Therapies.
    Nan H; Park C; Maeng S
    Biomed Res Int; 2020; 2020():2408402. PubMed ID: 33344633
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucopolysaccharidosis Type I in Children, a Forgotten Diagnosis Responsible for Undiagnosed Musculoskeletal Complaints: Report of Two Cases.
    Moghadam SH; Ghahvechi M; Mozafari F; Sayarifard F; Mousavi MS; Rostami R; Ziaee V
    Acta Medica (Hradec Kralove); 2019; 62(4):161-165. PubMed ID: 32036849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left-sided valvular heart disease and retinopathy in a 38-year-old woman with attenuated mucopolysaccharidosis: a case report.
    Asumda FZ; Kraker JA; Thomas SC; Maleszewski J; Stone EM; Lanpher BC; Schimmenti LA
    Ther Adv Rare Dis; 2023; 4():26330040221145945. PubMed ID: 37181073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Fluid Biomarkers Reveals Lysosome Dysfunction and Neurodegeneration in Neuronopathic MPS II Patients.
    Bhalla A; Ravi R; Fang M; Arguello A; Davis SS; Chiu CL; Blumenfeld JR; Nguyen HN; Earr TK; Wang J; Astarita G; Zhu Y; Fiore D; Scearce-Levie K; Diaz D; Cahan H; Troyer MD; Harris JM; Escolar ML
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in MPS I and MPS II Disease Manifestations.
    Hampe CS; Yund BD; Orchard PJ; Lund TC; Wesley J; McIvor RS
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Remodeling in an Mps-1h Girl after Hematopoietic Stem Cell Transplantation along with Enzymatic Replacement Therapy.
    Tummolo A; Brunetti G; Piacente L; Marzollo A; Biffi A; Burlina A; Faienza MF
    Endocr Metab Immune Disord Drug Targets; 2022; 22(14):1425-1432. PubMed ID: 35619307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac involvement in MPS patients: incidence and response to therapy in an Italian multicentre study.
    Sestito S; Rinninella G; Rampazzo A; D'Avanzo F; Zampini L; Santoro L; Gabrielli O; Fiumara A; Barone R; Volpi N; Scarpa M; Tomanin R; Concolino D
    Orphanet J Rare Dis; 2022 Jun; 17(1):251. PubMed ID: 35768874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucopolysaccharidosis VI.
    Valayannopoulos V; Nicely H; Harmatz P; Turbeville S
    Orphanet J Rare Dis; 2010 Apr; 5():5. PubMed ID: 20385007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment.
    Tomatsu S; Montaño AM; Oikawa H; Smith M; Barrera L; Chinen Y; Thacker MM; Mackenzie WG; Suzuki Y; Orii T
    Curr Pharm Biotechnol; 2011 Jun; 12(6):931-45. PubMed ID: 21506915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.